So-Young International Inc.

NASDAQ:SY

Medical - Healthcare Information Services

Healthcare
$1.83 -5.83%

-$0.09 today

Market cap
$239.36M
Beta
1.98
P/E (TTM)
-5.0
EPS (TTM)
-$1.95
52W Low $1.00High $6.28

Volume 0.46M

Average 0.63M

SY Interest Income

Income earned on cash, deposits, and investments held by the company.

So-Young International Inc.NASDAQ: SY

Interest Income · Q1 FY2026 · quarter ended Mar 2026

Interest income declines year over year

Q1 FY2026 interest income of CN¥3.92M fell 44.3% year over year, ahead of the -48.7% change in trailing-twelve-month interest income. Sequentially, it fell 6.0% from the prior quarter. Over 3 fiscal years it compounded at -5.2% a year.

Context

  • Interest income amounted to 1.7% of revenue in FY2025, down 1.5 pp from a year earlier.
  • Interest income increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -44.3% holds above the trailing-twelve-month pace of -48.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CN¥3.92M-6.0% QoQ
Last fiscal yearDec 2025
CN¥24.6M-47.1% YoY
LTMMar 2026
CN¥21.16M-48.7% YoY
Interest Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-44.3%——
1 year-47.1%——
3-year CAGR-5.2%——
5-year CAGR——
10-year CAGR——

Interest Income history

CNY · from the income statement

Latest · FY2025
24.6M CNY
Year-over-year change
-47.1%
4-year CAGR
+6.2%

Interest Income vs competitors

How SY compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -48.7% is the 7th highest of 11, against a peer median of -41.5%.
  • Interest income amounts to 1.3% of revenue for SY, versus a peer median of 5.5%.
SY Competitors
Interest Income for SY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYSo-Young International Inc.LTM Mar 2026CN¥21.16M CNY-48.7%-5.2%1.3%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$19.73M USD-35.4%+49.8%—
OMEROmeros CorporationLTM Mar 2026$16.69M USD+85.2%+7.6%168.7%
LABStandard BioTools Inc.LTM Mar 2026$9.77M USD-19.6%+60.4%11.3%
ADCTADC Therapeutics S.A.LTM Mar 2026$8.75M USD-23.1%+50.8%11.1%
LXRXLexicon Pharmaceuticals, Inc.LTM Mar 2026$6.23M USD-50.7%+63.0%8.9%
NMRANeumora Therapeutics, Inc. Common StockLTM Mar 2026$6.07M USD-63.6%+22.3%—
VREXVarex Imaging CorporationLTM Apr 2026$4.5M USD-47.7%+177.0%0.5%
SNDASonida Senior Living, Inc.LTM Mar 2026$2.08M USD+16.6%+107.6%0.5%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$1.71M USD-51.9%+12.2%2.1%
SLPSimulations Plus, Inc.LTM Feb 2026$964K USD-52.9%+0.2%1.2%
Peer median (excluding SY) —-41.5%+50.3%5.5%

Competitors are the stored peer set for SY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CNY
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.69B1.26B1.5B1.47B1.48B
Cost of Revenue327.89M393.29M544.34M567.59M774.04M
Gross Profit1.36B864.58M953.69M899.11M707.86M
Gross Margin80.6%68.7%63.7%61.3%47.8%
Research & Development286.57M235.09M203.52M165.03M133.31M
Selling, General & Admin1.04B732.3M811.22M818.57M833.76M
Operating Expenses1.4B967.39M1.01B1.52B967.07M
Depreciation & Amortization30.08M47.09M46.09M46.09M57.21M
EBITDA63.39M(39.99M)53.96M(38.39M)(182.19M)
EBITDA Margin3.7%-3.2%3.6%-2.6%-12.3%
Operating Income(32.57M)(102.81M)(61.05M)(624.49M)(259.21M)
Operating Margin-1.9%-8.2%-4.1%-42.6%-17.5%
Interest Income19.33M28.88M48.84M46.51M24.6M
Interest Expense00000
Other Income / Expenses16.17M15.73M68.92M36.41M19.8M
Income Before Tax(16.41M)(87.07M)7.87M(588.09M)(239.4M)
Pre-Tax Margin-1.0%-6.9%0.5%-40.1%-16.2%
Income Tax Expense21.23M(20.97M)(18.08M)(905K)(774.31K)
Net Income(8.37M)(65.55M)21.28M(589.53M)(235.7M)
Net Margin-0.5%-5.2%1.4%-40.2%-15.9%
EPS (Basic)(0.06)(0.48)0.16(4.40)(1.78)
EPS (Diluted)(0.06)(0.48)0.16(4.39)(1.78)
Weighted Avg Shares138.04M138.04M133.19M134.09M131.59M
Weighted Avg Shares (Diluted)138.04M138.04M131.91M134.16M131.59M

So-Young International Inc.

NASDAQ:SY

Intrinsic Alpha fair value

Locked

Current Price

$1.83

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.